Drug intelligence / Profile preview

SCD1 short hairpin RNA

Development stage
Preclinical
Lead developer
Sun Yat-sen University
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

SCD1 short hairpin RNA (shSCD1) is an experimental RNA interference (RNAi) agent designed to silence the expression of the stearoyl-CoA desaturase 1 (SCD1) enzyme. SCD1 is a critical, rate-limiting enzyme that catalyzes the synthesis of monounsaturated fatty acids (MUFAs), such as oleic acid, from saturated fatty acids. In various cancers, including hepatocellular carcinoma (HCC), SCD1 is often upregulated and plays a key role in lipid metabolic reprogramming. This reprogramming increases plasma membrane fluidity, which in turn promotes tumor cell invasive motility and metastasis, particularly in response to high matrix stiffness in the tumor microenvironment. By targeting SCD1 mRNA for degradation, shSCD1 reduces the levels of the SCD1 protein, thereby altering the cellular lipid profile, decreasing membrane fluidity, and inhibiting the metastatic potential of cancer cells. Research has demonstrated that knockdown of SCD1 using shRNA can suppress HCC invasion and metastasis in vivo.

Other names
shSCD1shSCD-1shSCD 1stearoyl-CoA desaturase 1 short hairpin RNASCD1-shRNASCD-1-shRNASCD 1-shRNA
02

Targets

SCD1 (Stearoyl-CoA desaturase 1)

Beyond the preview

Go deeper on SCD1 short hairpin RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCD1 short hairpin RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call